Open Label, Balanced, Randomized, Two-way, Single-dose, Crossover Bioequivalence Study of Alendronate Sodium 70 mg Tablets of Dr Reddy's, India and Fosamax Tablets of Merck and Co., Inc., USA, in Healthy Subjects Under Fasting Conditions.

Trial Profile

Open Label, Balanced, Randomized, Two-way, Single-dose, Crossover Bioequivalence Study of Alendronate Sodium 70 mg Tablets of Dr Reddy's, India and Fosamax Tablets of Merck and Co., Inc., USA, in Healthy Subjects Under Fasting Conditions.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jun 2010

At a glance

  • Drugs Alendronic acid (Primary)
  • Indications Corticosteroid-induced osteoporosis; Fracture; Male osteoporosis; Malignant hypercalcaemia; Osteitis deformans; Osteoporosis; Postmenopausal osteoporosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 03 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top